10.29
price down icon1.25%   -0.13
after-market 시간 외 거래: 10.35 0.06 +0.58%
loading
전일 마감가:
$10.42
열려 있는:
$10.38
하루 거래량:
7.21M
Relative Volume:
0.79
시가총액:
$12.00B
수익:
$14.33B
순이익/손실:
$-3.79B
주가수익비율:
-3.2461
EPS:
-3.17
순현금흐름:
$1.84B
1주 성능:
-0.96%
1개월 성능:
+8.09%
6개월 성능:
+24.73%
1년 성능:
-12.50%
1일 변동 폭
Value
$10.27
$10.46
1주일 범위
Value
$10.18
$10.52
52주 변동 폭
Value
$6.85
$13.55

비아트리스 Stock (VTRS) Company Profile

Name
명칭
Viatris Inc
Name
전화
(724) 514-1465
Name
주소
1000 MYLAN BOULEVARD, CANONSBURG
Name
직원
32,000
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
VTRS's Discussions on Twitter

VTRS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
10.29 12.03B 14.33B -3.79B 1.84B -3.17
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
145.41 65.38B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.10 44.75B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.12 40.97B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.78 22.50B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
415.34 19.04B 3.08B 1.24B 1.07B 25.61

비아트리스 Stock (VTRS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-15 개시 Truist Buy
2025-06-06 개시 Goldman Neutral
2024-07-19 재개 Jefferies Buy
2023-10-23 다운그레이드 BofA Securities Neutral → Underperform
2023-06-23 다운그레이드 Barclays Equal Weight → Underweight
2023-04-24 다운그레이드 Barclays Overweight → Equal Weight
2023-02-17 다운그레이드 BMO Capital Markets Outperform → Market Perform
2023-01-27 업그레이드 Jefferies Hold → Buy
2022-11-10 업그레이드 UBS Sell → Neutral
2022-11-08 업그레이드 Piper Sandler Underweight → Neutral
2022-10-21 재개 Jefferies Hold
2022-06-14 개시 UBS Sell
2022-05-10 다운그레이드 Piper Sandler Neutral → Underweight
2022-03-01 다운그레이드 BofA Securities Buy → Neutral
2022-03-01 다운그레이드 Raymond James Outperform → Mkt Perform
2021-06-15 개시 Citigroup Neutral
2021-04-07 재개 RBC Capital Mkts Outperform
2021-03-08 다운그레이드 Goldman Buy → Neutral
2021-03-02 다운그레이드 JP Morgan Overweight → Neutral
2021-02-26 다운그레이드 Wolfe Research Outperform → Peer Perform
2021-01-05 개시 Argus Hold
2020-12-14 개시 Bernstein Mkt Perform
모두보기

비아트리스 주식(VTRS)의 최신 뉴스

pulisher
12:32 PM

Viatris (VTRS) Backs Phage Therapy for Eye Infections Might Change The Case For Investing - simplywall.st

12:32 PM
pulisher
11:16 AM

Is Viatris (VTRS) Stock Undervalued Right Now? - sharewise.com

11:16 AM
pulisher
10:52 AM

Mydriasis Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia, Taejoon Pharma - Barchart.com

10:52 AM
pulisher
09:52 AM

Collaborating to Address Antimicrobial Resistance at Viatris - ACCESS Newswire

09:52 AM
pulisher
08:00 AM

Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections - Business Wire

08:00 AM
pulisher
04:57 AM

What does recent volatility data suggest for Viatris Inc.July 2025 Update & Short-Term High Return Ideas - newser.com

04:57 AM
pulisher
04:29 AM

Is Viatris Inc. (VIA) stock overpriced at current multiplesJuly 2025 Update & Reliable Entry Point Trade Alerts - Fundação Cultural do Pará

04:29 AM
pulisher
04:11 AM

Viatris Inc. stock outlook for YEARWeekly Market Report & Growth Focused Stock Pick Reports - newser.com

04:11 AM
pulisher
04:05 AM

Can volume confirm reversal in Viatris Inc.Portfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com

04:05 AM
pulisher
02:38 AM

Will Viatris Inc. stock benefit from upcoming earnings reportsEntry Point & Advanced Technical Signal Analysis - newser.com

02:38 AM
pulisher
02:27 AM

Will Viatris Inc. stock recover faster than peersJuly 2025 Patterns & Entry and Exit Point Strategies - newser.com

02:27 AM
pulisher
01:32 AM

Will Viatris Inc. stock reach Wall Street targetsTrade Exit Summary & High Return Trade Opportunity Guides - newser.com

01:32 AM
pulisher
Oct 27, 2025

Why analysts remain bullish on Viatris Inc. stockJuly 2025 Setups & Real-Time Market Sentiment Reports - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Will Viatris Inc. stock return to pre crisis levelsAnalyst Downgrade & Low Risk Investment Opportunities - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

What’s the recovery path for long term holders of Viatris Inc.Earnings Risk Report & AI Powered Trade Plan Recommendations - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Should you wait for a breakout in Viatris Inc.Insider Selling & Daily Chart Pattern Signal Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Viatris Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Viatris Inc. (VTRS) - 2822news.com

Oct 27, 2025
pulisher
Oct 25, 2025

Is Viatris Inc. stock a good choice for value investorsInsider Buying & Low Risk Entry Point Guides - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Viatris updates bylaws and sets 2026 annual meeting for May 15 - Investing.com Canada

Oct 25, 2025
pulisher
Oct 24, 2025

What Occidental Petroleum’s Latest Backer Sees in Oil’s Next Chapter - The Motley Fool

Oct 24, 2025
pulisher
Oct 24, 2025

Viatris updates bylaws and sets 2026 annual meeting for May 15 By Investing.com - Investing.com South Africa

Oct 24, 2025

비아트리스 (VTRS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_specialty_generic RDY
$14.60
price up icon 0.90%
$22.12
price down icon 0.67%
$47.12
price down icon 2.30%
$147.38
price down icon 1.05%
$415.34
price down icon 1.35%
자본화:     |  볼륨(24시간):